Skip Navigation


Human Molecular Genetics Advance Access originally published online on February 12, 2004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
13/7/669    most recent
ddh082v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (28)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ruan, Q.
Right arrow Articles by Johnson, G. V.W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruan, Q.
Right arrow Articles by Johnson, G. V.W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2004, Vol. 13, No. 7 669-681
DOI: 10.1093/hmg/ddh082

Striatal cells from mutant huntingtin knock-in mice are selectively vulnerable to mitochondrial complex II inhibitor-induced cell death through a non-apoptotic pathway

Qingmin Ruan1, Mathieu Lesort1, Marcy E. MacDonald2 and Gail V.W. Johnson1,*

1Department of Psychiatry, 1720 7th Avenue South, SC 1061, University of Alabama at Birmingham, Birmingham, AL 35294-0017, USA and 2Molecular Neurogenetics Unit, Massachusetts General Hospital, Building 149, 13th Street, Charlestown, MA 02129, USA

Received October 2, 2003; Accepted January 30, 2004

Extensive striatal neuronal loss occurs in Huntington's disease (HD), which is caused by an expanded polyglutamine tract in huntingtin (htt). Evidence suggests that mutant htt directly or indirectly compromises mitochondrial function, contributing to the neuronal loss. To determine the role of compromised mitochondrial function in the neuronal cell death in HD, immortalized striatal cells established from HdhQ7 (wild-type) and HdhQ111 (mutant) mouse knock-in embryos were treated with 3-nitropropionic acid (3-NP), a mitochondrial complex II toxin. 3-NP treatment caused significantly greater cell death in mutant striatal cells compared with wild-type cells. In contrast, the extent of cell death induced by rotenone, a complex I inhibitor, was similar in both cell lines. Although evidence of apoptosis was present in 3-NP-treated wild-type striatal cells, it was absent in 3-NP-treated mutant cells. 3-NP treatment caused a greater loss of mitochondrial membrane potential ({Delta}{psi}m) in mutant striatal cells compared with wild-type cells. Cyclosporine A, an inhibitor of mitochondrial permeability transition pore (PTP), and ruthenium red, an inhibitor of the mitochondrial calcium uniporter, both rescued mutant striatal cells from 3-NP-induced cell death and prevented the loss of {Delta}{psi}m. These data show that mutant htt specifically increases cell vulnerability to mitochondrial complex II inhibition and further switched the type of cell death induced by complex II inhibition from apoptosis to a non-apoptotic form, caused by mitochondrial membrane depolarization, probably initiated by mitochondrial calcium overload and subsequent PTP opening. These findings suggest that impaired mitochondrial complex II function in HD may contribute to non-apoptotic neuronal cell death.

* To whom correspondence should be addressed. Tel: +1 2059342465; Fax: +1 2059343709; Email: gvwj{at}uab.edu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 ScienceHome page
S. Subramaniam, K. M. Sixt, R. Barrow, and S. H. Snyder
Rhes, a Striatal Specific Protein, Mediates Mutant-Huntingtin Cytotoxicity
Science, June 5, 2009; 324(5932): 1327 - 1330.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Lim, L. Fedrizzi, M. Tartari, C. Zuccato, E. Cattaneo, M. Brini, and E. Carafoli
Calcium Homeostasis and Mitochondrial Dysfunction in Striatal Neurons of Huntington Disease
J. Biol. Chem., February 29, 2008; 283(9): 5780 - 5789.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
G. Giordano, C. C. White, I. Mohar, T. J. Kavanagh, and L. G. Costa
Glutathione Levels Modulate Domoic Acid Induced Apoptosis in Mouse Cerebellar Granule Cells
Toxicol. Sci., December 1, 2007; 100(2): 433 - 444.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Milakovic, R. A. Quintanilla, and G. V. W. Johnson
Mutant Huntingtin Expression Induces Mitochondrial Calcium Handling Defects in Clonal Striatal Cells: FUNCTIONAL CONSEQUENCES
J. Biol. Chem., November 17, 2006; 281(46): 34785 - 34795.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
J. M. A. Oliveira, S. Chen, S. Almeida, R. Riley, J. Goncalves, C. R. Oliveira, M. R. Hayden, D. G. Nicholls, L. M. Ellerby, and A. C. Rego
Mitochondrial-Dependent Ca2+ Handling in Huntington's Disease Striatal Cells: Effect of Histone Deacetylase Inhibitors
J. Neurosci., October 25, 2006; 26(43): 11174 - 11186.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
A. Solans, A. Zambrano, M. Rodriguez, and A. Barrientos
Cytotoxicity of a mutant huntingtin fragment in yeast involves early alterations in mitochondrial OXPHOS complexes II and III
Hum. Mol. Genet., October 15, 2006; 15(20): 3063 - 3081.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
A. Benchoua, Y. Trioulier, D. Zala, M.-C. Gaillard, N. Lefort, N. Dufour, F. Saudou, J.-M. Elalouf, E. Hirsch, P. Hantraye, et al.
Involvement of Mitochondrial Complex II Defects in Neuronal Death Produced by N-Terminus Fragment of Mutated Huntingtin
Mol. Biol. Cell, April 1, 2006; 17(4): 1652 - 1663.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
I. S. Seong, E. Ivanova, J.-M. Lee, Y. S. Choo, E. Fossale, M. Anderson, J. F. Gusella, J. M. Laramie, R. H. Myers, M. Lesort, et al.
HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism
Hum. Mol. Genet., October 1, 2005; 14(19): 2871 - 2880.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Milakovic and G. V. W. Johnson
Mitochondrial Respiration and ATP Production Are Significantly Impaired in Striatal Cells Expressing Mutant Huntingtin
J. Biol. Chem., September 2, 2005; 280(35): 30773 - 30782.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
T. Nguyen, A. Hamby, and S. M. Massa
Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model
PNAS, August 16, 2005; 102(33): 11840 - 11845.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.